Ziprasidone and quetiapine. One goes better fast, one slow. Also the mystery of ghost pills, and a research update on pramipexole.

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.

The FDA just approved Ketarx for surgical pain, but the company has its eyes on depression.

Meds that require special skill to start: Atomoxetine and prazosin, plus a new FDA warning on stimulants.

Meds that require special skill to start: Antipsychotics, Cobenfy, and a research update on antidepressant metabolism in Asians.

Before you cook, oil the pan; before you plant that spring lawn, aerate the soil. Before you start a psych med, these are six things you need to have in place.

We interview psychoanalyst William Meyer on a therapeutic approach to postpartum depression.

We look at how often postpartum depression converts to bipolar, and what that means for treatment.

Today, we are focusing on how families are responding mentally and emotionally to disaster, and how children process loss when a parent or caregiver dies.

Brexanolone has quietly exited the pharmaceutical stage, and we look at what that means for its stand-in, zuranolone (Zurzuvae), in postpartum depression.